4D Molecular Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
I'm Tazeen Ahmad. I'm one of the Senior SMID biotech analysts here at Bank of America. It's my pleasure to have our next presenting company management with us, specifically 4D Molecular Therapeutics.
With me for the next 30 minutes are a couple of members from the management team, Fred Kamal as well as CEO, David Kirn.
So David, I think while we're getting the slides situated, I think it's probably good for us to get an intro with the company, if you could for a couple of minutes, and then we can go into more details either on the slides or on Q&A.
Absolutely. Well, thanks for having us today, and good to see you all. At 4D Molecular Therapeutics, we're harnessing the power of directed evolution, which is a Nobel Prize-winning technology to invent customized AAV vectors for any tissue in the body, and we think this translates into best-in-class products across
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |